Medical cannabis white paper released as Australia moves towards legalisation

MGC Pharmaceuticals has been collaborating with the University of Sydney Business School community engagement program in the production of a medical cannabis white paper.

The paper, titled Clinical Evidence for Medical Cannabis: Epilepsy, Cancer and Multiple Sclerosis examines existing evidence supporting the efficacy of medical cannabis.

This second collaboration between the two also examines medical cannabis applicability to relieve associated symptoms for a range of health related issues, including pain nausea and loss of appetite.

For…